Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Non Operating Investment Income (2024)

Tonix Pharmaceuticals Holding (TNXP) has 1 years of Non Operating Investment Income data on record, last reported at -$855000.0 in Q2 2024.

  • For Q2 2024, Non Operating Investment Income changed N/A year-over-year to -$855000.0; the TTM value through Dec 2024 reached $6.1 million, changed N/A, while the annual FY2024 figure was $6.1 million, N/A changed from the prior year.
  • Non Operating Investment Income reached -$855000.0 in Q2 2024 per TNXP's latest filing, down from $7.0 million in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $7.0 million in Q1 2024 and bottomed at -$855000.0 in Q2 2024.